Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nuvation Bio Inc (NY: NUVB ) 2.750 +0.010 (+0.36%) Official Closing Price Updated: 7:00 PM EDT, Aug 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nuvation Bio Inc < Previous 1 2 3 Next > Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data August 05, 2024 Nuvation Bio halts its NUV-868 BET inhibitor program after Phase 1 study analysis. The decision impacts solid tumor treatments in ovarian, pancreatic, and mCRPC cancers, focusing instead on late-stage... Via Benzinga Nuvation Bio Reports Second Quarter 2024 Financial Results and Provides Business Update August 05, 2024 From Nuvation Bio Inc. Via Business Wire Nuvation Bio Announces Updates and Upcoming Presentations for its ROS1 Inhibitor, Taletrectinib July 23, 2024 From Nuvation Bio Inc. Via Business Wire NeuroBo Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying June 26, 2024 Via Benzinga Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting June 01, 2024 From Nuvation Bio Inc. Via Business Wire Nuvation Bio to Present at the Jefferies Global Healthcare Conference May 29, 2024 From Nuvation Bio Inc. Via Business Wire NUVB Stock Earnings: Nuvation Bio Beats EPS for Q1 2024 May 14, 2024 NUVB stock results show that Nuvation Bio beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update May 14, 2024 From Nuvation Bio Inc. Via Business Wire Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting April 24, 2024 From Nuvation Bio Inc. Via Business Wire Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday April 19, 2024 Via Benzinga Nuvation Bio Completes Acquisition of AnHeart Therapeutics April 10, 2024 From Nuvation Bio Inc. Via Business Wire ProfoundBio Discovers The Joys Of Having A Wealthy Owner April 08, 2024 Key Takeaways: Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion The deal is the fourth acquisition of a China-related innovative drugmaker by a... Via Benzinga Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session April 03, 2024 U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday. Via Benzinga Week In Review: AriBio Sells China Rights To Alzheimer’s Candidate In $770 Million Deal March 30, 2024 South Korea’s AriBio out-licensed China rights for AR1001, an Alzheimer’s disease candidate, in an agreement worth up to $770 million. The company acquiring the asset asked to remain anonymous because... Via Talk Markets Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer March 28, 2024 From Nuvation Bio Inc. Via Business Wire 12 Health Care Stocks Moving In Wednesday's Intraday Session March 27, 2024 Via Benzinga Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 27, 2024 Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates. Via Benzinga Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday March 27, 2024 U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Wednesday's Pre-Market Session March 27, 2024 Via Benzinga Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday March 27, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket March 27, 2024 Shares of MariaDB plc (NYSE: MRDB) rose sharply in today’s pre-market trading after Progress Software (NASDAQ: PRGS) announced that it is possibly considering an offer for the company. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday March 27, 2024 It's time to dive into the biggest pre-market stock movers for Wednesday morning as we check out all of the hottest news! Via InvestorPlace Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 26, 2024 Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session March 26, 2024 Via Benzinga Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday March 26, 2024 U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Pre-Market Session March 25, 2024 Via Benzinga Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction March 25, 2024 From Nuvation Bio Inc. Via Business Wire Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session March 25, 2024 U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading. Via Benzinga Topics Stocks Exposures US Equities Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors March 14, 2024 From Nuvation Bio Inc. Via Business Wire 12 Health Care Stocks Moving In Thursday's Pre-Market Session March 14, 2024 Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.